The purpose of the Indiana Tuberculosis Prevention & Care Program is to progress toward elimination of TB by conducting prevention activities through education, outreach, collaboration, and surveillance.
Available via Purdue Pharmacy as of April 9, 2026: Rifampin (4R) and Isoniazid, Rifampin (3HR), and Rifapentine (3HP)
Alternate: Isoniazid (6H/9H)
Medication Update - Rifabutin is currently on a manufacturer backorder.
Local Health Departments and Public Health Nurses should confer with their regional nurse consultants when deciding on prescription options.
TB Tips for Infection Preventionists (pdf)
Heartland TB Center Isolation Guidance (pdf)
Discharge Planning Checklist (pdf) - This is a sample, and there is no requirement to use this template. Please follow applicable local policies and procedures.
Contact Investigation Templates
Indiana APIC Conference Poster TB & Infection Prevention Resources (pdf)
TB Reportable Condition Reporting Guidance
LTBI Reportable Condition Reporting Guidance
TB/LTBI NBS Quick Guides & Workflows
On-Demand Training
CDC TB 101 for Health Care Workers GTBI TB 101 Series CDC TB Self-Study Modules APHL Understanding TB Laboratory Testing for Public Health Nurses
APHL Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices
IDOH TB Program TST Online Course
SNTC When TB is the Least of Their Worries: Mini-Course series
Upcoming Training
GTBI TB Intensive Workshop GTBI Fundamentals of TB Contact Investigation
Complex TB Case Across Multiple Jurisdictions
World TB Day Summit 2026
TB Prevention & Care Program Updates for LHDs 12-14-23 (pdf) and recording link
IDOH Lab Webcast TB presentation 12-13-23 (pdf)
TB-Refugee Health New LHD PHN Program Orientation 12-7-23 (pdf)
What a LHD Administrator Should Know About TB (pdf)
What Happens After a Positive TST or IGRA (pdf)
TB Update (pdf)
TB Prevention & Case Management: Core Services & Isolation Updates (pdf)
Page last reviewed/updated: April 2026
